JNJ
Dividend royalty, still doing dividend things
Johnson & Johnson is back with another reminder that it’s basically the Beyoncé of dividend consistency: 64 straight years of increases. This time, the company said it’s lifting its quarterly payout by 3.1%.
Why you should care
If you own JNJ for income, this is the part where the snowball keeps rolling downhill. Dividend raises don’t usually make for flashy headline-grabbing fireworks, but they do signal confidence in cash flow and management’s willingness to keep rewarding shareholders.
The fine print, minus the snooze factor
A small raise can still matter a lot over time, especially for long-term holders reinvesting those payouts. And for a mega-cap healthcare name like J&J, another increase is less “surprise!” and more “yep, the machine is still humming.”
Big picture: when a company has spent 64 years hiking its dividend, it’s telling you it wants to be the financial equivalent of a metronome — steady, predictable, and very annoying to anyone trying to bet against it.